The Board of Starpharma announced the appointment of Ms. Lynda Cheng as an independent non-executive director, effective 1 August 2021. Ms. Cheng will join the Audit and Risk Committee upon her appointment. Ms. Cheng has more than 25 years of experience as a finance executive including more than 15 years at Visy Industries/Pratt Holdings and 10 years in investment banking. Ms. Cheng is currently Director of Corporate Development and Mergers & Acquisitions at Visy Industries /Pratt Holdings and has held various other roles in the group including CFO. Ms. Cheng is currently a non-executive director of Export Finance Australia and a member of the Wesley College Council.